No More Copays for Vital Medications: Michigan Senate Proposes New Legislation
In a significant move to ease financial burdens on families, the Michigan Senate introduced bills on Wednesday aimed at eliminating copays for essential medications such as asthma inhalers, insulin, and epinephrine. These proposed measures could lead to significant savings for many in the state.
The legislation would mandate that health insurers cover the full cost of prescription inhalers, insulin, and epinephrine. State Senator Darrin Camilleri (D-Trenton), a co-sponsor of this legislative package, emphasized the positive impact of such a policy on household budgets.
“These are three pieces of medicine that we know are widely used by our population and we know would directly impact their bottom line for residents, as they’re dealing with making budgeting decisions. So, if we can save a family $50 a month on a copay, that’s a big deal,” Camilleri stated during a Senate session on Thursday.
However, gaining bipartisan support is essential for advancing these bills through the Republican-controlled state House of Representatives, as Camilleri noted that he had yet to engage his Republican peers on this issue.
Efforts to enhance health care affordability have encountered obstacles in the current legislative session, with several bills stalling in both chambers. These include proposals to establish a state board to cap drug prices and to enforce hospital price transparency.
State Senator Chedrick Greene (D-Saginaw) advocates for bipartisan cooperation to lower medication costs and improve accessibility, arguing, “We can’t do anything without breathing. We can pile all the money, we can pass all the legislation we can, but if we’re struggling to breathe, then we’re not doing anything,” he emphasized the need to prioritize common sense measures that benefit the most vulnerable individuals.
—
Read More Michigan News
